Evidence-Based Medicine Guidelines
Interferon for hepatitis C related cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon for Hepatitis C Related Cirrhosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450023/all/Interferon_for_hepatitis_C_related_cirrhosis.
Interferon for hepatitis C related cirrhosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/450023/all/Interferon_for_hepatitis_C_related_cirrhosis. Accessed November 23, 2024.
Interferon for hepatitis C related cirrhosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450023/all/Interferon_for_hepatitis_C_related_cirrhosis
Interferon for Hepatitis C Related Cirrhosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450023/all/Interferon_for_hepatitis_C_related_cirrhosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon for hepatitis C related cirrhosis
ID - 450023
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450023/all/Interferon_for_hepatitis_C_related_cirrhosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
